Application
Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);Application
Figure 1: Western blot analysis using KRT19 mAb against human KRT19 (AA: 115-269) recombinant protein. (Expected MW is 43.1 kDa)Application
Figure 2: Western blot analysis using KRT19 mouse mAb against T47D (1), MCF-7 (2), HepG2 (3) and SW620 (4) cell lysate.Application
Figure 3: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissues using KRT19 mouse mAb with DAB staining.Application
Figure 4: Immunohistochemical analysis of paraffin-embedded human colon cancer tissues using KRT19 mouse mAb with DAB staining.Application
Figure 5: Immunohistochemical analysis of paraffin-embedded human stomach cancer tissues using KRT19 mouse mAb with DAB staining.Application
Figure 6: Immunohistochemical analysis of paraffin-embedded human bladder cancer tissues using KRT19 mouse mAb with DAB staining.Application
Figure 7: Immunofluorescence analysis of HepG2 cells using KRT19 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.| Product Name | KRT19 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | K19; CK19; K1CS; MGC15366 |
| Immunogen | Purified recombinant fragment of human KRT19 expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | K19 CK19 K1CS MGC15366 |
|---|---|
| Molecular Weight(MW) | 41kDa |
| Entrez Gene | 3880 |
|---|
Application
Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);
Application
Figure 1: Western blot analysis using KRT19 mAb against human KRT19 (AA: 115-269) recombinant protein. (Expected MW is 43.1 kDa)
Application
Figure 2: Western blot analysis using KRT19 mouse mAb against T47D (1), MCF-7 (2), HepG2 (3) and SW620 (4) cell lysate.
Application
Figure 3: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissues using KRT19 mouse mAb with DAB staining.
Application
Figure 4: Immunohistochemical analysis of paraffin-embedded human colon cancer tissues using KRT19 mouse mAb with DAB staining.
Application
Figure 5: Immunohistochemical analysis of paraffin-embedded human stomach cancer tissues using KRT19 mouse mAb with DAB staining.
Application
Figure 6: Immunohistochemical analysis of paraffin-embedded human bladder cancer tissues using KRT19 mouse mAb with DAB staining.
Application
Figure 7: Immunofluorescence analysis of HepG2 cells using KRT19 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
